Advertisement

Chronic Administration of Stimulant Drugs: Response Modification

  • M. Marlyne Kilbey
  • Everett H. EllinwoodJr.
Part of the Advances in Behavioral Biology book series (ABBI, volume 21)

Abstract

Tolerance, lack of tolerance, and reverse tolerance of physiological and behavioral responses have been reported to develop with multiple administrations of stimulant drugs (Magos, 1969; Klawans, Corsett, and Dana, 1975; Kalant, Le Blanc, and Gibbins, 1971; Kosman and Unna, 1968; and Schuster, Dockens, and Woods, 1966). Stimulants that have been investigated include cocaine, amphetamine in its various isomers and analogs, and methylphenidate. Dosages have been used that produce sustained normal activity, hyperactivity, stereotyped behavior, anorexia, and hyperthermia. Changes in these measures with multiple administrations have been evaluated in man, monkey, cat, guinea pig, and mouse. As work in this area has developed, it has become increasingly apparent that a multiplicity of drug-, subject-, behavioral-, and environmental factors, as well as the interactions of these factors, must be specified if one hopes to correlate the observed changes in response to drug with changes in biological parameters in order to elucidate neurochemical mechanisms.

Keywords

Chronic Administration Stereotyped Behavior Stimulant Drug Multiple Administration Stereotyped Response 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Beuthin, F.C., Miya, R.S., Blake, D.E., and Bosquet, W.F.: Enhanced sensitivity to noradrenergic agonists and tolerance development to a-methyl-tyrosine in the rat, J. Pharmac. exp. Ther. 181, 446–456 (1972).Google Scholar
  2. Corrodi, H., Fuxe, K., Ljungdahl, A., and Ogren, S-O.: Studies on the action of some psychoactive drugs on central noradrenaline neurones after inhibition of dopamine-ß-hydroxylase, Brain Res. 24, 451–470 (1970).PubMedCrossRefGoogle Scholar
  3. Dominic, J.A. and Moore, K.E.: Supersensitivity to the central stimulant actions of adrenergic drugs following discontinuation of a chronic diet of methyltyrosine, Psychopharmacologia 15, 96–101 (1969).PubMedCrossRefGoogle Scholar
  4. Ellinwood, E.H.: Amphetamine psychosis: I. Description of the individuals and process, J. nerv. ment. Dis. 144, 273–283 (1967).CrossRefGoogle Scholar
  5. Ellinwood, E.H.: Amphetamine psychosis: II. Theoretical implications, J. Neuropsychiat. 4, 45–54 (1968).Google Scholar
  6. Ellinwood, E.H.: Effect of chronic methamphetamine intoxication in rhesus monkeys, Biol. Psychiat. 3, 25–32 (1971).Google Scholar
  7. Ellinwood, E.H. and Balster, R.L.: Rating the behavioral effects of amphetamines, Eur. J. Pharmacol. 28, 35–41 (1974).PubMedCrossRefGoogle Scholar
  8. Ellinwood, E.H. and Kilbey, M.M.: Amphetamine stereotypy: The influence of environmental factors and prepotent behavioral patterns on its topography and development, Biol. Psychiat. 10, 3–16 (1975a).Google Scholar
  9. Ellinwood, E.H. and Kilbey, M.M.: Species differences in response to amphetamine. In: Psychopharmacogenetics. Eleftheriou, B.L., Ed., pp. 323–375. New York: Plenum Press, 1975b.CrossRefGoogle Scholar
  10. Ellinwood, E.H. and Sudilovsky, A.: Chronic amphetamine intoxication: Behavioral model of psychoses. In: Psychopathology and Psychopharmacology. Cole, J.O., Freedman, A.M., and Friedhoff, A.J., Eds., Baltimore: Johns Hopkins University Press, 1973a. pp. 51–70.Google Scholar
  11. Ellinwood, E.H. and Sudilovsky, A.: The relationship of the amphetamine model psychosis to schizophrenia. In: Psychopharmacology, Sexual Disorders and Drug Abuse. Ban, T.A., Boissier, J.R., Gessa, G.J., Heimann, H., Hollister, L., Lehmann, H.E., Munkvad, I., Steinberg, H., Sulser, F., Sundwall, A., and Vinar, O., Eds., Amsterdam and London: North-Holland Publishing Company; Prague: Avicenum, Czechoslovak Medical Press, 1973b. pp. 189–203.Google Scholar
  12. Ernest, A.M.: The role of biogenic amines in the extrapyramidal system, Acta physiol. pharmac. néerl. 15, 141–154 (1969).Google Scholar
  13. Fog, R.A., Randrup, A., and Pakkenberg, H.: Aminergic mechanisms in corpus striatum and amphetamine-induced stereotyped behavior, Psychopharmacologia 2, 179–183 (1967).CrossRefGoogle Scholar
  14. Geyer, M.A. and Segal, D.S.: Differential effects of reserpine and alpha-methyl-p-tyrosine on norepinephrine and dopamine induced behavioral activity, Psychopharmacologia 29, 131–140 (1973).PubMedCrossRefGoogle Scholar
  15. Goldstein, M. and Nakajima, K.: The effect of disulfiram on catecholamine levels in the brain, J. Pharmac. exp. Ther. 157, 96–102 (1967).Google Scholar
  16. Gunne, L.M. and Lewander, T.: Brain catecholamines during chronic amphetamine intoxication, Res. Publs Ass. Res. nerv. ment. Dis. 46, 106–116 (1966).Google Scholar
  17. Ho, B.: Behavioral effects of cocaine: Metabolic and neurochemical approach. In: Cocaine and Other Stimulants. Ellinwood, E.H. and Kilbey, M.M., Eds. New York: Plenum Press, 1976.Google Scholar
  18. Iversen, S.D. and Iversen, L.L.: Behavioral Pharmacology. New York: Oxford University Press, 1975.Google Scholar
  19. Kalant, H., Le Blanc, A.E., and Gibbins, R.J.: Tolerance to, and dependence on, some non-opiate psychotropic drugs, Pharmac. Rev. 23, 135–191 (1971).Google Scholar
  20. Klawans, H.L., Corsett, P., and Dana, N.: Effect of chronic amphetamine exposure on stereotyped behavior: Implications for pathogenesis of 1-dopa-induced dyskinesias, Adv. Neurol. 9, 105–112 (1975).Google Scholar
  21. Kosman, M.E. and Unna, K.R.: Effects of chronic administration of the amphetamines and other stimulants on behavior, Clin. Pharmacol. Therap. 9, 240–254 (1968).Google Scholar
  22. Lal, S. and Sourkes, T.I.: Potentiation and inhibition of the amphetamine stereotypy in rats by neuroleptics and other agents, Archs in Pharmacodyn. Thér. 199, 289–301 (1972).Google Scholar
  23. Lewander, T.: Urinary excretion and tissue levels of catecholamines during chronic amphetamine intoxication, Psychopharmacologia 13, 394–407 (1968).PubMedCrossRefGoogle Scholar
  24. Lu, T.C., Ho, B.T., and Mclssac, W.M.: Effects of repeated administration of DL-amphetamine and methamphetamine on tolerance to hyperactivity, Experientia 28, 1461 (1972).PubMedCrossRefGoogle Scholar
  25. Magos, L.: Persistence of the effect of amphetamine on stereotyped activity in rats, Eur. J. Pharmacol. 6, 200–201 (1969).PubMedCrossRefGoogle Scholar
  26. Maickel, R.P., Cox, R.H., Miller, F.P., Segal, D.S., and Russell, R.W.: Correlation of brain levels of drugs with behavioral effects, J. Pharmac. exp. Ther. 165, 216–224 (1969).Google Scholar
  27. Sahakian, B.J., Robbins, T.W., Morgan, M.J., and Iversen, S.D.: The effects of psychomotor stimulants on stereotypy and loco-motor activity in socially-deprived and control rats, Brain Res. 84, 195–205 (1975).PubMedCrossRefGoogle Scholar
  28. Schidrring, E.: Amphetamine induced selective stimulation of certain behaviour items with concurrent inhibition of others in an openfield test with rats, Behaviour 39, 1–17 (1971).CrossRefGoogle Scholar
  29. Schuster, C.R., Dockens, W.S., and Woods, J.H.: Behavioral variables affecting the development of amphetamine tolerance, Psychopharmacologia 9, 170–182 (1966).PubMedCrossRefGoogle Scholar
  30. Segal, D.S.: Behavioral and neurochemical correlates of repeated d-amphetamine administration. In: Neurobiological Mechanisms of Adaptation and Behavior. Mandell, A.J., Ed., pp. 247–262. New York: Raven Press, 1975.Google Scholar
  31. Seiden, L.S., Fischman, M.W., and Schuster, C.R.: Changes in brain catecholamine induced by long-term methamphetamine administration in rhesus monkeys. In: Cocaine and Other Stimulants. Ellinwood, E.H. and Kilbey, M.M., Eds. New York: Plenum Press, 1976.Google Scholar
  32. Sudilovsky, A., Ellinwood, E.H., Dorsey, F., and Nelson, L.: Evaluation of the Duke University Behavioral Rating Inventory for Drug Generated Effects (BRIDGE). In: Prediction in Psycho-pharmacology: Preclinical and Clinical Correlations. Sudilovsky, A., Gershon, S., and Beer, B., Eds., pp. 189–212. New York: Raven Press, 1975.Google Scholar
  33. Winer, B.J.: Statistical Principles in Experimental Design. New York: McGraw-Hill, 1962.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1977

Authors and Affiliations

  • M. Marlyne Kilbey
    • 1
  • Everett H. EllinwoodJr.
    • 1
  1. 1.Behavioral Neuropharmacology Section Department of PsychiatryDuke University Medical CenterDurhamUSA

Personalised recommendations